Nutrien Ltd. Q2 FY26 Results — Earnings Call Analysis

Published 29 May 2026 | Chemicals | Market Cap: ₹33.6K Cr

- Nutrein maintains full-year guidance with expected sales volumes of potash at 14.1 to 14.8 million tonnes and nitrogen at 9.2 to 9.7 million tonnes for 2026. - Nutrien maintains full-year guidance with confidence, supported by strong Q1 performance and ongoing operational excellence.

From Nutrien Ltd.'s Q2 FY26 earnings-call transcript · updated 29 May 2026.

Price

69.65

Market Cap

₹33.6K Cr

P/E Ratio

14.2

Revenue Rank

Rank 3

Margin Rank

Rank 3

How does Nutrien Ltd. rank in Chemicals?

Compare Nutrien Ltd. against every Chemicals company this quarter on revenue, margins and earnings-call signals.

Revenue: Rank 3Margin: Rank 3
View Chemicals leaderboard →

📊 Revenue & Sales Performance

Rank 3
  • Nutrein maintains full-year guidance with expected sales volumes of potash at 14.1 to 14.8 million tonnes and nitrogen at 9.2 to 9.7 million tonnes for 2026.
  • Strong global demand supports sustaining or increasing sales, with potash shipments forecasted between 74 to 77 million tonnes, indicating potential growth beyond last year's 74.5 million tonnes.
  • High single-digit growth anticipated in proprietary products gross margin, driven by new product launches and expansion in core retail geographies including the U.S., Australia, and international markets.
  • Retail business remains constructive with maintained EBITDA guidance of $1.75 to $1.95 billion for 2026, supported by strong customer engagement and expanding proprietary products.
  • Growth is partly driven by crop nutrient replenishment needs following a large 2025 corn and soybean harvest and increased acres planted in key markets.
  • Ongoing strategic reviews and portfolio optimization, including potential sales in certain business segments, aim to strengthen core growth areas.

📈 Profitability & Margins

Rank 3
  • Nutrien maintains full-year guidance with confidence, supported by strong Q1 performance and ongoing operational excellence.
  • High single-digit growth expected in proprietary products gross margin in 2026 due to new product launches, increased demand, and international expansion.
  • No major changes anticipated in margin expectations across product segments except some pressure on phosphate margins in Q2 due to elevated input costs.
  • The company is constructive on potash demand and expects shipment range of 74-77 million tonnes in 2026, testing global logistics and production capacity.
  • Nitrogen segment benefits from higher global benchmarks and low-cost production, driving strong adjusted EBITDA.
  • Retail adjusted EBITDA guidance remains $1.75 billion to $1.95 billion with strong customer engagement during planting season.
  • Nutrien is focused on cost management, asset optimization, and capital allocation to sustain structural free cash flow growth and returns.
  • Overall, market conditions and strategic initiatives support positive earnings outlook and stable profitability for 2026.

🏗️ Capital Expenditure Plans

Yes
  • **2026 Capital Expenditures Guidance:** Maintained at $2 billion to $2.1 billion.
  • **Strategic Reviews:**
  • - Phosphate business: Completing detailed assessment of assets and configurations; progressing a sale process with significant initial expressions of interest.
  • - Trinidad nitrogen operations: Evaluating all strategic options, including potential sale, focused on strengthening core North American assets.
  • - Brazilian business: Reviewing components and commenced sales process for Brazilian soybean seed business, expected to complete in H2 2026.
  • **Capital Allocation:** Continuing share repurchases at approximately $55 million per month in Q2 2026.
  • **Investment Focus:** Simplifying the business, strengthening core asset base, improving capital efficiency to drive structural free cash flow growth and sustainable returns.

💰 Fundraising & Capital Structure

No information
  • The company completed share repurchases of approximately $550 million last year and reduced adjusted net debt by approximately $600 million.
  • In 2026, they plan to continue share repurchases on a ratable basis with a pace of approximately $55 million per month so far in the second quarter.
  • They see opportunities to further strengthen the balance sheet in 2026.
  • There is no explicit mention of new fundraising through debt or equity during the call.
  • The focus remains on consistent capital allocation, optimizing the portfolio, and maintaining a strong balance sheet.

📋 Order Book & Pipeline

No information
The provided pages do not explicitly state current or expected orderbook or pending orders in numeric terms. However, relevant insights include: - Prior to the Middle East conflict, approximately 35% of second quarter planned nitrogen sales volumes were committed, similar to the prior year. - Canpotex (potash exporter) is fully committed through the end of June. - For nitrogen, sales volume guidance remains 9.2 to 9.7 million tonnes with planned turnarounds at 3 facilities in 2026. - Retail inventories are expected to be very empty towards the end of spring, indicating anticipated refill orders. - Strong customer engagement and product movement have been reported thus far into 2026. - Inventory remains short due to ongoing Middle East disruptions, impacting over 30% of global urea trade and 25% of ammonia and phosphate. - Market remains tight with supply-demand fundamentals expected to keep pricing and demand elevated near term. No exact numerical order backlog or pending order values provided.

Key Metrics

Revenue

Rank 3

Margin

Rank 3

Capex

Yes

Fundraise

No information

Order Book

No information

Others in Chemicals this season

  • Westlake Corporation (Q2 FY26)

    Westlake Corporation Q2 FY26 quarterly results analysis. HIP segment volume growth driven by strong infrastructure spending and data center cooling needs, suppo

  • RPM International Inc. (Q2 FY26)

    RPM International Inc. Q2 FY26 quarterly results analysis. RPM expects mid-single-digit revenue growth in Q4 fiscal ’26, aided by M&A (Page 4). Market Cap $13,6

  • Solstice Advanced Materials, Inc. (Q2 FY26)

    Solstice Advanced Materials, Inc. Q2 FY26 quarterly results analysis. Strong momentum heading into Q2 with 5 planned maintenance outages on track (Page 9). Mark

  • International Flavors & Fragrances Inc. (Q2 FY26)

    International Flavors & Fragrances Inc. Q2 FY26 quarterly results analysis. The company expects solid top-line growth driven by volume growth across all segment

Frequently Asked Questions

What were Nutrien Ltd. Q2 FY26 results?

- Nutrein maintains full-year guidance with expected sales volumes of potash at 14.1 to 14.8 million tonnes and nitrogen at 9.2 to 9.7 million tonnes for 2026. - Nutrien maintains full-year guidance with confidence, supported by strong Q1 performance and ongoing operational excellence.

What is Nutrien Ltd. share price analysis?

Nutrien Ltd. currently shows a below-average growth signal. The stock trades at a P/E of 14.2 with a market cap of $33,569. Investors should review the full earnings analysis for detailed insights.

Is Nutrien Ltd. planning capital expenditure?

- **2026 Capital Expenditures Guidance:** Maintained at $2 billion to $2.1 billion.

Keep Nutrien Ltd. on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.